Suppr超能文献

单核核糖核酸测序和空间转录组学揭示了麝香保心丸(SBP)对心肌缺血再灌注损伤小鼠的心脏保护作用。

Single-nucleus ribonucleic acid-sequencing and spatial transcriptomics reveal the cardioprotection of Shexiang Baoxin Pill (SBP) in mice with myocardial ischemia-reperfusion injury.

作者信息

Lin Wenyong, Chen Xin, Wang Dongyuan, Lu Ruixia, Zhang Chunling, Niu Zhenchao, Chen Jie, Ruan Xiaofen, Wang Xiaolong

机构信息

Branch of National Clinical Research Center for Chinese Medicine Cardiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Cardiovascular Research Institute of Traditional Chinese Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Front Pharmacol. 2023 May 9;14:1173649. doi: 10.3389/fphar.2023.1173649. eCollection 2023.

Abstract

The Shexiang Baoxin Pill (SBP) has been extensively used to treat cardiovascular diseases in China for four decades, and its clinical efficacy has been widely approved. However, the mechanism by which this is achieved remains largely unexplored. Research attempting to understand the underlying mechanism is ongoing, but the findings are controversial. Here, we aimed to explore the possible mechanism of SBP in myocardial ischemia-reperfusion (I/R) injury using heart single-nucleus and spatial ribonucleic acid (RNA) sequencing. We established a murine myocardial I/R injury model in C57BL/6 mice by ligating and recanalizing the left coronary artery anterior descending branch. Subsequently, single-nucleus RNA-seq and spatial transcriptomics were performed on mice cardiac tissue. We initially assessed the status of cell types and subsets in the model administered with or without SBP. We used single-nucleus RNA sequencing to comprehensively analyze cell types in the cardiac tissue of sham, I/R, and SBP mice. Nine samples from nine individuals were analyzed, and 75,546 cells were obtained. We classified the cells into 28 clusters based on their expression characteristics and annotated them into seven cell types: cardiomyocytes, endothelial cells, fibroblasts, myeloid cells, smooth muscle cells, B cells, and T cells. The SBP group had distinct cellular compositions and features than the I/R group. Furthermore, SBP-induced cardioprotection against I/R was associated with enhanced cardiac contractility, reduced endocardial cell injury, increased endocardial-mediated angiogenesis, and inhibited fibroblast proliferation. In addition, macrophages had active properties. SBP improves the early LVEF of I/R mice and has a cardioprotective effect. Through sequencing analysis, we observed that SBP can increase the gene expression of and in the infarct area of the heart. is related to vascular generation mediated by endocardial cells and requires further research. In addition, SBP increases the number of fibroblasts, inhibits the expression of genes related to fibroblast activation and proliferation, and increases the transformation of endothelial cells into fibroblasts. These findings will help to indicate directions for further research.

摘要

麝香保心丸(SBP)在中国已广泛用于治疗心血管疾病达四十年之久,其临床疗效已得到广泛认可。然而,其实现疗效的机制在很大程度上仍未被探索。试图了解潜在机制的研究正在进行中,但研究结果存在争议。在此,我们旨在通过心脏单核和空间核糖核酸(RNA)测序探索SBP在心肌缺血再灌注(I/R)损伤中的可能机制。我们通过结扎和再通左冠状动脉前降支在C57BL/6小鼠中建立了小鼠心肌I/R损伤模型。随后,对小鼠心脏组织进行单核RNA测序和空间转录组学分析。我们首先评估了给予或未给予SBP的模型中细胞类型和亚群的状态。我们使用单核RNA测序全面分析假手术组、I/R组和SBP组小鼠心脏组织中的细胞类型。对来自九个个体的九个样本进行了分析,共获得75,546个细胞。我们根据细胞的表达特征将其分为28个簇,并将它们注释为七种细胞类型:心肌细胞、内皮细胞、成纤维细胞、髓样细胞、平滑肌细胞、B细胞和T细胞。SBP组与I/R组的细胞组成和特征不同。此外,SBP诱导的对I/R的心脏保护作用与增强心脏收缩力、减少心内膜细胞损伤、增加心内膜介导的血管生成以及抑制成纤维细胞增殖有关。此外,巨噬细胞具有活跃的特性。SBP改善I/R小鼠的早期左心室射血分数(LVEF)并具有心脏保护作用。通过测序分析,我们观察到SBP可以增加心脏梗死区域中[具体基因1]和[具体基因2]的基因表达。[具体基因1]与心内膜细胞介导的血管生成有关,需要进一步研究。此外,SBP增加成纤维细胞数量,抑制与成纤维细胞激活和增殖相关的基因表达,并增加内皮细胞向成纤维细胞的转化。这些发现将有助于为进一步的研究指明方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30ae/10203427/ba1607fdaf0e/FPHAR_fphar-2023-1173649_wc_abs.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验